NCT05312255View on ClinicalTrials.gov

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

NARecruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

June 28, 2027

Study Completion Date

June 28, 2027

Conditions
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell MyelomaSmoldering Plasma Cell Myeloma
Interventions
BEHAVIORAL

Behavioral Intervention

Wear a FitBit device and receive prompts for 6 months

DRUG

Beta-Adrenergic Antagonist

Receive beta-blocker regimen as per SOC

DRUG

Propranolol

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Resistance Training

Undergo strength training for 6 months

OTHER

Short-Term Fasting

Participate in intermittent fasting

Trial Locations (1)

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER